Ivlev and colleagues49 have published the most recent systematic review on prostate cancer screening patient decision aids and concluded that integration of decision aids in clinical practice may result in a decrease in the number of men who elect to undergo PSA testing, which may in turn reduce screening uptake. This evidence concerns the gene KLK3 and Familial prostate cancer.